全文获取类型
收费全文 | 76篇 |
免费 | 3篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 21篇 |
基础医学 | 2篇 |
临床医学 | 5篇 |
内科学 | 9篇 |
皮肤病学 | 2篇 |
神经病学 | 2篇 |
外科学 | 24篇 |
综合类 | 3篇 |
眼科学 | 8篇 |
中国医学 | 1篇 |
出版年
2020年 | 1篇 |
2019年 | 2篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2014年 | 12篇 |
2013年 | 1篇 |
2012年 | 6篇 |
2011年 | 1篇 |
2010年 | 1篇 |
2009年 | 4篇 |
2008年 | 4篇 |
2007年 | 6篇 |
2006年 | 2篇 |
2005年 | 3篇 |
2004年 | 4篇 |
2003年 | 4篇 |
2002年 | 5篇 |
2001年 | 3篇 |
1999年 | 1篇 |
1998年 | 2篇 |
1996年 | 1篇 |
1990年 | 1篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1981年 | 2篇 |
1975年 | 2篇 |
排序方式: 共有79条查询结果,搜索用时 140 毫秒
1.
Anil S Paramesh Ralph B Fairchild Theresa M Quinn Fred Leya Magdalene George David H Van Thiel 《Liver transplantation》2005,11(2):236-238
A 53-year-old male with hepatitis C cirrhosis, who had been refused liver transplantation because of hypertrophic cardiomyopathy (HC), underwent nonsurgical septal ablation using alcohol with resolution of his ventricular outflow obstruction. This patient was able to subsequently undergo a successful deceased donor liver transplantation. This is the first reported case of alcohol induced septal ablation being performed in a cirrhotic patient with HC. Such nonsurgical procedures may be attractive in cirrhotic patients who are refused access to liver transplantation because of high surgical risk. 相似文献
2.
Paramesh H 《Indian journal of pediatrics》1996,63(2):181-187
Respiratory diseases are a major cause of morbidity and mortality in developing countries. Recurrent respiratory infections
in children pose a great challenge to the pediatrician where he has to exercise his clinical acumen and methodical, approach,
for correct diagnosis and treatment.
It is a fact that children should suffer 7 to 8 upper respiratory infections per year until they are 5 years of age when their
immune status reaches adult level. In this situation, it is essential to find out whether the frequencies are abnormal. Whenever
a child has the following, problems, then only it needs to be investigated.—(a) repeated bacterial pneumonias; (b) a child less than 3 months old having repeated respiratory infections; (c) a child of 9 months old without a history of exposure infections; (d) infections, complicating into bronchiectasis and; (e) in a child where there is no history of allergy or asthma.
Once the problem is established as a true recurrent respiratory infection, the clinician should pose questions—whether it
is chronic, acute or recurrent, to find out the site of pathology, seriousness of the problem, response to previous medications,
to establish the possible diagnosis which fall into six categories—congenital anamolies, aspiration syndrome, genital disorders,
immunological, diseases, immune deficiency disorders and allergic diseases.
The author discusses quoting some examples for various categories avoiding non pulmonary causes for recurrent respiratory
infections in children. 相似文献
3.
Douglass A Morrison Gulshan Sethi Jerome Sacks William Henderson Frederick Grover Steven Sedlis Rick Esposito Kodagundi B Ramanathan Darryl Weiman J David Talley Jorge Saucedo Tamim Antakli Venki Paramesh Stuart Pett Sarah Vernon Vladimir Birjiniuk Frederick Welt Mitchell Krucoff Walter Wolfe John C Lucke Sundeep Mediratta David Booth Charles Barbiere Dan Lewis 《Journal of the American College of Cardiology》2002,39(2):266-273
OBJECTIVES: This study was designed to compare the three-year survival after percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) in physician-directed and patient-choice registries with the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) randomized trial results. BACKGROUND: The AWESOME multicenter randomized trial and registry compared the long-term survival after PCI and CABG for the treatment of patients with medically refractory myocardial ischemia and at least one additional risk factor for adverse outcome with CABG. The randomized trial demonstrated comparable three-year survival. METHODS: Over a five-year period (1995 to 2000), 2,431 patients with medically refractory myocardial ischemia and at least one of five risk factors (prior heart surgery, myocardial infarction within seven days, left ventricular ejection fraction <0.35, age >70 years, intra-aortic balloon required to stabilize) were identified. By physician consensus, 1,650 patients formed a physician-directed registry assigned to CABG (692), PCI (651) or further medical therapy (307), and 781 were angiographically eligible for random allocation; 454 of these patients constitute the randomized trial, and the remaining 327 constitute a patient choice registry. Survival for CABG and PCI was compared using Kaplan-Meier curves and log-rank tests. RESULTS: The CABG and PCI 36-month survival rates for randomized patients were 79% and 80%, respectively. The CABG and PCI 36-month survival rates were both 76% for the physician-directed subgroup; comparable survival rates for the patient-choice subgroup were 80% and 89%, respectively. None of the global log-rank tests for survival demonstrated significant differences. CONCLUSIONS: Both registries support the randomized trial conclusion: PCI is an alternative to CABG for some medically refractory high-risk patients. 相似文献
4.
5.
Rubin Zhang Heather LaGuardia Anil Paramesh Katherine Mills Mary Killackey Jennifer McGee Brent Alper Eric Simon Lotuce Lee Hamm Douglas Slakey 《Transplant international》2013,26(6):601-607
Transplanting single pediatric donor kidneys into adult recipients has an increased risk of hyperfiltration injury and graft loss. It is unknown if renin‐angiotensin system (RAS) blockers are beneficial in this setting. We retrospectively analyzed 94 adults who received single kidneys from donors <10 years old during 1996–2009. The recipients were divided into group 1 with RAS blockers (n = 40) and group 2 without RAS blockers (n = 54) in the first year of transplant. There was no significant difference in any donor/recipient demographic between the two groups. Graft function, incidence of delayed graft function, acute rejection, and persistent proteinuria were not statistically different either. Kaplan–Meier estimated death‐censored graft survivals were significantly better in group 1 than in group 2: 95 vs. 81.2%, 82.4 vs. 61.2%, 72.6 vs. 58.5%, and 68.5 vs. 47.2% at 1, 3, 5, and 7 years, respectively (log rank P = 0.043). Multivariable analysis found persistent proteinuria was a risk factor for graft loss (OR 2.70, 95% CI 1.33–5.49, P = 0.006), while RAS blockers reduced the risk of graft loss (OR 0.38, 95% CI 0.18–0.79, P = 0.009). Early RAS blockade therapy in the first year of transplant is associated with superior long‐term graft survival among adults transplanted with single pediatric donor kidneys. 相似文献
6.
7.
Manu Tomar Raghavendra Pralhada Rao Palaniyamma Dorairaj Abhishek Koshta Sowbhagya Suresh Mohamed Rafiq Rajesh Kumawat Rangesh Paramesh Babu U. V K. V. Venkatesh 《RSC advances》2019,9(39):22288
Correction for ‘A clinical and computational study on anti-obesity effects of hydroxycitric acid’ by Manu Tomar et al., RSC Adv., 2019, 9, 18578–18588.The authors regret that the name of one of the authors (Raghavendra Pralhada Rao) was shown incorrectly in the original article. The corrected author list is as shown above.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers. 相似文献
8.
Manu Tomar Raghavendra Prahlad Rao Palaniyamma Dorairaj Abhishek Koshta Sowbhagya Suresh Mohamed Rafiq Rajesh Kumawat Rangesh Paramesh Babu U. V K.
V. Venkatesh 《RSC advances》2019,9(32):18578
Hydroxycitric acid (HCA), a major active ingredient of Garcinia cambogia extracts, is known to suppress body weight gain and fat synthesis in animals and humans. But the underlying mechanism of HCA action is not fully understood. Clinical study on 100 obese individuals for a period of 3 months was performed followed by a computational study aimed to investigate the effects of HCA treatment on human subjects at anthropometric and plasma lipid profile levels. A detailed hepatic metabolic model was used to incorporate the effect of HCA at the metabolic pathway level. Perturbation analysis of ATP citrate lyase activity in the metabolic pathway was performed to simulate the net effect of HCA. Significant reductions in body weight, triceps, subscapular, and mid axillary measurements as well as in serum triglyceride, cholesterol, HDL and LDL levels were observed following HCA dosage. During the study, half of the subjects experienced a decline in body weight and the remainder experienced an increase in body weight. However, analysis of fat mass with the help of empirical correlations clearly showed significant reduction in the mean values due to HCA dosage in both cases. An extra increase in fat free mass was responsible for offsetting the decrease in fat mass for the subjects who experienced an increase in body weight during the trials. Perturbation analysis showed a net reduction in fatty acid, triglyceride and cholesterol synthesis along with urea cycle fluxes under lipogenetic conditions. Moreover, protein synthesis fluxes increased under these conditions. These results indicate that HCA treatment can reduce body weight gain and fat accumulation in obese subjects along with improving their anthropometric parameters and metabolic state.Hydroxycitric acid (HCA), a major active ingredient of Garcinia cambogia extracts, is known to suppress body weight gain and fat synthesis in animals and humans. 相似文献
9.
During the first few months of life after birth human infants when tested monocularly move their unoccluded eye nasalward in darkness after viewing a large textured visual field moving either nasalward or temporalward. The eye movements in darkness are optokinetic after nystagmus (OKAN) which is an aftereffect of a reflex horizontal following eye movement, optokinetic nystagmus (OKN). Not until 4-5 months of age did temporalward field motion evoke OKAN with temporalward slow phase. The nasalward slow phase of OKAN that responded earlier to temporalward field motion appears to underlie the delayed development of reflex following eye movements in the temporalward direction. 相似文献
10.
EditorWe read with interest the review article by Moloneyand Griffiths1 on protective ventilation of patients with acuterespiratory distress syndrome (ARDS). Recent insights into pulmonarymechanics have led to a re-evaluation of the role of positiveend-expiratory pressure (PEEP) in ventilated ARDS patients.We felt that the authors did not highlight this issue correctly.In their review, the 相似文献